Friday, July 3, 2026

< + > DUOS Acquires Linkwell Health | Withings Acquires Biosency

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.


DUOS Acquires Linkwell Health to Strengthen Its Performance Infrastructure for Health Plan Outcomes

The Acquisition Deepens DUOS’ AI-Powered Activation Layer, Creating a Unified Platform that Serves One in Five U.S. Adults from Enrollment to Care Completion to Health Outcomes

DUOS, the performance infrastructure for health plans, today announced its acquisition of Linkwell Health, strengthening the end-to-end system DUOS has built to turn health plan investments into realized member outcomes. Following the acquisition, DUOS expands its footprint to more than 20 health plans nationwide and extends its reach to one in five U.S. adults.

Health plans invest heavily in benefits, quality programs, care coordination, and risk strategies, but too often the return falls short because of a persistent follow-through gap, the distance between what a plan designs for members and the actions members take. DUOS closes that gap through an integrated performance infrastructure bringing together member activation, government program enrollment, care coordination, and medication safety into a single system designed to improve plan performance.

With the acquisition of Linkwell Health, DUOS deepens its AI-powered activation layer with predictive content intelligence, omnichannel delivery, and personalized engagement journeys that turn outreach into action.

“Health plans have spent years adding benefits and buying point solutions. The hard part was never access. It was follow-through,” said Karl Ulfers, Co-Founder and CEO at DUOS. “The return gets lost in the gap between what’s designed and what members actually do. That is the follow-through gap, and it is one of the most expensive inefficiencies in healthcare. Competitors converge data. DUOS connects with the member and closes the loop. With this acquisition, we are widening that moat and strengthening the infrastructure layer health plans use to drive performance.”

The impact is measurable. Across its platform, DUOS has delivered 85% Annual Wellness Visit completion rates, 60% HEDIS gap closure, and up to +1.5 Stars improvement for health plan partners…

Full release here, originally announced June 23rd, 2026.


Withings Acquires Biosency and Enters Respiratory Remote Monitoring

Withings, a leader in connected health, today announced the acquisition of Biosency, a Rennes-based company specializing in the monitoring of patients with respiratory insufficiency. With Biosency, Withings deepens its remote monitoring capabilities and reinforces its ambition to build a strong, independent European player supporting the transformation of healthcare systems.

Recognized Expertise in Respiratory Health

Founded in 2017 in Rennes, Biosency has developed a modular remote monitoring solution for patients with respiratory insufficiency and their caregivers. The solution notably includes a medically certified algorithm capable of detecting COPD exacerbations at an early stage. The company brings several years of clinical research in COPD, a certified technology, and an established presence in the French healthcare system.

A Value-Creating Combination

Backed by Withings’ industrial expertise, Biosency will be able to focus on the commercialization and scaling of its solution while leveraging the Group’s broader ecosystem. Continuity of the solution, its certification, and its ongoing support for patients and healthcare professionals will be fully maintained.

“I was impressed by Biosency’s medical rigor and the quality of its research in COPD. I see a strong alignment between the detection of respiratory exacerbations and the work we are doing in the monitoring of cardiometabolic diseases,” said Éric Carreel, President at Withings…

Full release here, originally announced June 22nd, 2026.



No comments:

Post a Comment

< + > Stop Getting Surprised by Shortages: Building Real-Time Medication Visibility Across the Enterprise

The following is a guest article by Kilee Yarosh, Senior Manager, Clinical Strategists at Omnicell Everyone in healthcare has lived some ve...